4//SEC Filing
Gaston-Dreyfus Remi 4
Accession 0001144204-18-036313
CIK 0001508381other
Filed
Jun 27, 8:00 PM ET
Accepted
Jun 28, 2:20 PM ET
Size
5.5 KB
Accession
0001144204-18-036313
Insider Transaction Report
Form 4
Gaston-Dreyfus Remi
Director
Transactions
- Conversion
Common Stock
2018-06-13$0.06/sh+15,740,728$983,796→ 91,204,117 total(indirect: Shares held through RGD Investissements and Lombard International Assurance SA)
Footnotes (1)
- [F1]As previously disclosed by the reporting person on a Form 4, filed with the Securities and Exchange Commission on April 3, 2018, as of March 31, 2018, the Issuer became obligated to issue 15,740,728 shares of common stock (the "Shares") to RGD Investissements, an affiliate of the reporting person, as a result of the conversion of certain outstanding convertible promissory notes in accordance with their terms. The reporting person is filing this Form 4 to disclose that the Issuer issued the Shares as of June 13, 2018.
Documents
Issuer
Bionik Laboratories Corp.
CIK 0001508381
Entity typeother
Related Parties
1- filerCIK 0001716639
Filing Metadata
- Form type
- 4
- Filed
- Jun 27, 8:00 PM ET
- Accepted
- Jun 28, 2:20 PM ET
- Size
- 5.5 KB